Michael J. Thorpy

5.1k total citations
107 papers, 3.0k citations indexed

About

Michael J. Thorpy is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Endocrine and Autonomic Systems. According to data from OpenAlex, Michael J. Thorpy has authored 107 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Cognitive Neuroscience, 65 papers in Experimental and Cognitive Psychology and 31 papers in Endocrine and Autonomic Systems. Recurrent topics in Michael J. Thorpy's work include Sleep and Wakefulness Research (84 papers), Sleep and related disorders (65 papers) and Circadian rhythm and melatonin (21 papers). Michael J. Thorpy is often cited by papers focused on Sleep and Wakefulness Research (84 papers), Sleep and related disorders (65 papers) and Circadian rhythm and melatonin (21 papers). Michael J. Thorpy collaborates with scholars based in United States, France and Czechia. Michael J. Thorpy's co-authors include Ana C. Krieger, Robert J. Shprintzen, Aaron E. Sher, Arthur J. Spielman, Daniel J. Buysse, Richard Bogan, Charles H. Adler, Paul B. Glovinsky, Peter A. McGregor and Bernard Burack and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michael J. Thorpy

99 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Thorpy United States 27 1.7k 1.7k 1.0k 682 440 107 3.0k
David Davila United States 19 1.8k 1.0× 2.0k 1.1× 950 0.9× 809 1.2× 541 1.2× 25 3.1k
Stephen P. Duntley United States 24 994 0.6× 969 0.6× 902 0.9× 981 1.4× 291 0.7× 43 2.6k
Vincenza Castronovo Italy 25 1.2k 0.7× 1.1k 0.6× 996 1.0× 1.1k 1.6× 318 0.7× 50 2.7k
In‐Young Yoon South Korea 32 1.0k 0.6× 1.1k 0.6× 840 0.8× 1.1k 1.6× 436 1.0× 139 3.1k
Rochelle Zak United States 27 1.8k 1.0× 1.5k 0.9× 1.4k 1.3× 1.3k 1.9× 875 2.0× 56 3.8k
Todd J. Swick United States 19 2.1k 1.2× 2.3k 1.3× 1.6k 1.6× 1.4k 2.1× 395 0.9× 34 3.9k
Thomas Röth United States 32 2.2k 1.2× 2.4k 1.4× 1.0k 1.0× 654 1.0× 461 1.0× 83 3.5k
Vincent Mysliwiec United States 26 721 0.4× 1.3k 0.7× 454 0.4× 599 0.9× 492 1.1× 96 2.5k
Mark R. Pressman United States 21 1.3k 0.8× 1.0k 0.6× 712 0.7× 921 1.4× 456 1.0× 45 2.5k
Maria Basta Greece 31 1.4k 0.8× 2.1k 1.2× 1.0k 1.0× 1.1k 1.6× 245 0.6× 108 3.6k

Countries citing papers authored by Michael J. Thorpy

Since Specialization
Citations

This map shows the geographic impact of Michael J. Thorpy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Thorpy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Thorpy more than expected).

Fields of papers citing papers by Michael J. Thorpy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Thorpy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Thorpy. The network helps show where Michael J. Thorpy may publish in the future.

Co-authorship network of co-authors of Michael J. Thorpy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Thorpy. A scholar is included among the top collaborators of Michael J. Thorpy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Thorpy. Michael J. Thorpy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Thorpy, Michael J., Lois E. Krahn, Chad Ruoff, & Nancy Foldvary‐Schaefer. (2024). Clinical considerations in the treatment of idiopathic hypersomnia. Sleep Medicine. 119. 488–498. 2 indexed citations
3.
Thorpy, Michael J., Jerome M. Siegel, & Yves Dauvilliers. (2024). REM sleep in narcolepsy. Sleep Medicine Reviews. 77. 101976–101976. 7 indexed citations
4.
Parthasarathy, Sairam, et al.. (2024). Social support and isolation in narcolepsy and idiopathic hypersomnia: An international survey. Sleep Medicine. 125. 65–73.
6.
Corser, Bruce, Richard Bogan, Jennifer C. Franco, et al.. (2023). 0585 A four-week randomized, double-blind, placebo-controlled, phase 2 study of mazindol ER in the treatment of narcolepsy. SLEEP. 46(Supplement_1). A257–A257. 2 indexed citations
8.
Morse, Anne Marie, Yves Dauvilliers, Isabelle Arnulf, et al.. (2023). Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. Journal of Clinical Sleep Medicine. 19(10). 1811–1822. 9 indexed citations
9.
Dauvilliers, Yves, Richard Bogan, Karel Šonka, et al.. (2022). Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. SHILAP Revista de lepidopterología. 7 indexed citations
10.
Bogan, Richard, et al.. (2022). 0386 Long-term Safety During a Clinical Trial of Lower-Sodium Oxybate in Participants With Narcolepsy With Cataplexy. SLEEP. 45(Supplement_1). A173–A173. 1 indexed citations
11.
Roth, Thomas, Yves Dauvilliers, Michael J. Thorpy, et al.. (2022). Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial. CNS Drugs. 36(4). 377–387. 20 indexed citations
12.
Dauvilliers, Yves, Nancy Foldvary‐Schaefer, Richard Bogan, et al.. (2021). Cataplexy-Free Days in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Narcolepsy With Cataplexy (2065). Neurology. 96(15_supplement). 1 indexed citations
13.
Rosenthal, León, Michael J. Thorpy, Soňa Nevšímalová, et al.. (2021). 2018 worldwide survey of health-care providers caring for patients with narcolepsy. Sleep Medicine. 82. 23–28. 4 indexed citations
15.
Thorpy, Michael J., et al.. (2007). Managed care considerations.. PubMed. 13(6 Suppl). S148–53.
16.
Thorpy, Michael J.. (2005). Which clinical conditions are responsible for impaired alertness?. Sleep Medicine. 6. S13–S20. 19 indexed citations
17.
Thorpy, Michael J., et al.. (1992). Short-Term Triazolam Use Improves Nocturnal Sleep of Narcoleptics. SLEEP. 15(3). 212–216. 59 indexed citations
18.
Thorpy, Michael J., et al.. (1988). Effect of Growth Hormone Treatment on Sleep EEGs in Growth Hormone-Deficient Children. SLEEP. 11(5). 425–429. 22 indexed citations
19.
Goldstein, Steven, et al.. (1987). Reversibility of deficient sleep entrained growth hormone secretion in a boy with achondroplasia and obstructive sleep apnea. European Journal of Endocrinology. 116(1). 95–101. 63 indexed citations
20.
Crosley, Carl J., R Richman, & Michael J. Thorpy. (1980). Evidence for cortisol-independent anticonvulsant activity of adrenocorticotropic hormone in infantile spasms. Annals of Neurology. 8(2). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026